YAG Laser Vitreolysis for Vitreous Floaters
NCT: NCT06915922 · COMPLETED
広告
NCT識別子NCT06915922
ステータスCOMPLETED
開始日2023-10-17
完了2026-08-13
SponsorVMR Consulting, Inc. (OTHER)
First posted
Last updated
概要
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。